![]() |
![]() |
Teisinis statusas
Patentas galioja
(51) | INT.CL. | C07D 271/06 | (2006.01) |
C07D 285/08 | (2006.01) | ||
A61K 31/4245 | (2006.01) | ||
A61K 31/433 | (2006.01) | ||
A61K 31/395 | (2006.01) | ||
C07D 273/00 | (2006.01) | ||
C07D 273/08 | (2006.01) |
(11) | Patento numeris | 3041827 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 14790320.7 |
Europos patento paraiškos padavimo data | 2014-09-05 | |
(97) | Europos patento paraiškos paskelbimo data | 2016-07-13 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-18 |
(46) | Apibrėžties vertimo paskelbimo data | 2018-07-25 |
(86) | Numeris | PCT/IB2014/064279 |
Data | 2014-09-05 |
(87) | Numeris | WO 2015/033299 |
Data | 2015-03-12 |
(30) | Numeris | Data | Šalis |
4011CH2013 | 2013-09-06 | IN |
(72) |
SASIKUMAR, Pottayil Govindan Nair, IN
RAMACHANDRA, Muralidhara, IN
NAREMADDEPALLI, Seetharamaiah Setty Sudarshan, IN
|
(73) |
Aurigene Discovery Technologies Limited,
39-40 KIADB Industrial Area Electronic City Phase-II Hosur Road, Bangalore, Karnataka 560100,
IN
|
(74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 1,2,4-Oksadiazolo dariniai, kaip imunomoduliatoriai |
1,2,4-OXADIAZOLE DERIVATIVES AS IMMUNOMODULATORS |
Mokėjimo data | Galiojimo metai | Suma | |
2025-08-25 | 12 | 289.00 EUR |
2026-09-05 |